The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Q3 2015 Review with Immune Pharmaceuticals, Inc. - Update on Clinical and Corporate Developments

SNNLive caught up with Dr. Daniel Teper, CEO of Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) at the Dawson James Small Cap Growth Conference 2015 in Jupiter, FL.

Share With

Monday, November 02, 2015

   

© 2017 Stock News Now